SmartTab Attends the Crohn's & Colitis Foundation's IBD Innovate Conference
By Sacha Heppell - November 08, 2021
The SmartTab team will attend the IBD INNOVATE: Product Development for Crohn’s & Colitis™ Conference November 18-19. This event will showcase innovative product development programs in IBD and offer extensive partnering and networking opportunities. SmartTab looks forward to connecting with innovators in the IBD space to partner on the development of SmartTab's novel drug delivery systems. A networking opportunity for all stakeholders dedicated to advancing products to address the critical challenges faced by IBD patients. The 2021 program will take place on an interactive virtual conference platform, with live Q&A, research talks and poster sessions. Attendees are also encouraged to take advantage of matchmaking software for 1:1 partnering.
The conference target audience is startup companies, accelerator organizations (industry, non-profit & academic), industry representatives (R&D, clinical development, external R&D, scouting, partnering, business development, corporate venture), academic researchers, investors (venture capital & other), disease foundations and other non-profit funders, contract research organizations, service providers, clinicians, and patient advocates.
"Our team is looking forward to joining the IBD Innovate conference and meetings that forward SmartTab and transform the future of drug delivery."
-Robert Niichel, SmartTab, CEO
SmartTab is dedicated to patient-centered innovation and sponsored the Rocky Mountain Crohn's and Colitis Foundation. SmartTab completed Patient Focus Groups designed to fuel our commitment to building more effective patient delivery systems. SmartTab recently received the Autoimmune Patients' Choice Award. SmartTab is committed to transforming drug delivery for IBD and beyond.